Abstract
Context: Celtis australis L. (Ulmaceae) is a deciduous tree distributed in mountainous and sub-mountainous Himalaya. This plant has been used as traditional medicine in bone fracture, pimples, contusions, sprains and joint pains in India.
Objectives: This is the first evaluation of C. australis extracts (bark and fruits) and fatty acids (fruits) for acute toxicity, analgesic, and anti-inflammatory activities.
Materials and methods: The ethanol extracts of air dried stem bark and fruits were prepared at 30-50°C with 95% EtOH for 15h. The solvent was evaporated under reduced pressure and the powdery extracts so obtained were used for present study along with crude fatty acids obtained from column elution of n-C6H12-CHCl3 (6:4) of EtOAc fruit extract. Crude extracts and fatty acids were screened for analgesic and anti-inflammatory activities by oral administration of three different doses at 100, 250 and 500 mg/kg of each text sample on Swiss albino mice and Sprague-Dawley rats, respectively.
Results: All doses (i.e. 100, 250, and 500 mg/kg) of test samples were found active when compared with negative control. Crude extracts and fatty acids at higher concentration (i.e. 500 mg/kg) showed analgesic activity protection of 59.28, 63.22, and 45.79%, respectively, whereas at the same concentration, the anti-inflammatory inhibition was 44.26, 45.90, and 42.62%, respectively. Paracetamol and phenylbutazone were used as positive controls for analgesic and antiinflammatory activities, respectively.
Discussion and conclusion: Present study concludes that extracts (stem bark and fruits) and fatty acids (fruits) of C. australis have significant (p<0.05) analgesic and anti-inflammatory activities.
Keywords: Ulmaceae, acetic acid, carrageenean, triterpenoid, phenolic, phenylbutazone, traditional medicine, analgesic and anti-inflammatory, activities.
The Natural Products Journal
Title:Analgesic and Anti-Inflammatory Activities of Extracts and Fatty Acids from Celtis australis L
Volume: 2 Issue: 4
Author(s): Ruchi B. Semwal and Deepak K. Semwal
Affiliation:
Keywords: Ulmaceae, acetic acid, carrageenean, triterpenoid, phenolic, phenylbutazone, traditional medicine, analgesic and anti-inflammatory, activities.
Abstract: Context: Celtis australis L. (Ulmaceae) is a deciduous tree distributed in mountainous and sub-mountainous Himalaya. This plant has been used as traditional medicine in bone fracture, pimples, contusions, sprains and joint pains in India.
Objectives: This is the first evaluation of C. australis extracts (bark and fruits) and fatty acids (fruits) for acute toxicity, analgesic, and anti-inflammatory activities.
Materials and methods: The ethanol extracts of air dried stem bark and fruits were prepared at 30-50°C with 95% EtOH for 15h. The solvent was evaporated under reduced pressure and the powdery extracts so obtained were used for present study along with crude fatty acids obtained from column elution of n-C6H12-CHCl3 (6:4) of EtOAc fruit extract. Crude extracts and fatty acids were screened for analgesic and anti-inflammatory activities by oral administration of three different doses at 100, 250 and 500 mg/kg of each text sample on Swiss albino mice and Sprague-Dawley rats, respectively.
Results: All doses (i.e. 100, 250, and 500 mg/kg) of test samples were found active when compared with negative control. Crude extracts and fatty acids at higher concentration (i.e. 500 mg/kg) showed analgesic activity protection of 59.28, 63.22, and 45.79%, respectively, whereas at the same concentration, the anti-inflammatory inhibition was 44.26, 45.90, and 42.62%, respectively. Paracetamol and phenylbutazone were used as positive controls for analgesic and antiinflammatory activities, respectively.
Discussion and conclusion: Present study concludes that extracts (stem bark and fruits) and fatty acids (fruits) of C. australis have significant (p<0.05) analgesic and anti-inflammatory activities.
Export Options
About this article
Cite this article as:
B. Semwal Ruchi and K. Semwal Deepak, Analgesic and Anti-Inflammatory Activities of Extracts and Fatty Acids from Celtis australis L, The Natural Products Journal 2012; 2 (4) . https://dx.doi.org/10.2174/2210315511202040323
DOI https://dx.doi.org/10.2174/2210315511202040323 |
Print ISSN 2210-3155 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-3163 |
Call for Papers in Thematic Issues
Ayurvedic medicinal therapeutic approaches for inflammatory and neurodegenerative disorders
Usually, in our elderly population, neurodegenerative disorders occur due to neuron death. Alzheimer?s disease (AD) is an irreversible and progressive neurodegenerative disease. Dementia is the leading cause of AD, which affects about 30 million people worldwide. According to the World Alzheimer report 2018, a new case of dementia develops every ...read more
Recent Advances in Biotransformation of Bioactive Terpenoids using Aspergillus niger
Biotransformation is the reaction catalyzed by biological catalysts of either isolated enzymes or whole cell cultures of microorganisms. This process has been extensively applied in the conversion of bioactive terpenoids with high regio- and stereospecifity. This process has been also applied in the lead discovery and development. Aspergillus niger has ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
An Overview of the Pharmacological Properties and Potential Applications of Natural Monoterpenes
Mini-Reviews in Medicinal Chemistry Antibodies Against Recombinant Catalytic Domain of Lethal Toxin of Clostridium sordellii Neutralize Lethal Toxin Toxicity in HeLa Cells
Protein & Peptide Letters Diagnostic Cardiac Catheterization in the Pediatric Population
Current Cardiology Reviews Rapid Desensitization of Hypersensitivity Reactions to Chemotherapy Agents.
Current Drug Safety Targeting Nanoparticles as Drug Delivery Systems for Cancer Treatment
Current Nanoscience Norepinephrine in Goal-Directed Fluid Therapy During General Anesthesia in Elderly Patients Undergoing Spinal Operation: Determining Effective Infusion Rate to Enhance Postoperative Functions
Current Genomics Vascular Risk Factors and Neurodegeneration in Ageing Related Dementias: Alzheimer’s Disease and Vascular Dementia
Current Alzheimer Research Isoniazid: Metabolic Aspects and Toxicological Correlates
Current Drug Metabolism Pegfilgrastim-Apgf (Nyvepria): Biosimilar USFDA Approval for the Treatment of Chemotherapy-induced Febrile Neutropenia and Current Updates on Clinical Trials
Current Drug Targets Therapeutic Hypothermia and Neuroprotection in Acute Neurological Disease
Current Medicinal Chemistry Sex Steroid Hormones, Cardiovascular Diseases and The Metabolic Syndrome
Cardiovascular & Hematological Agents in Medicinal Chemistry Simultaneous Determination of Cytochrome P450 Oxidation Capacity in Humans: A Review on the Phenotyping Cocktail Approach
Current Pharmaceutical Biotechnology On the Origin of Cortical Dopamine: Is it a Co-Transmitter in Noradrenergic Neurons?
Current Neuropharmacology Chemotherapy and Delivery in the Treatment of Primary Brain Tumors
Current Clinical Pharmacology Serotonin 1A Receptors on Astrocytes as a Potential Target for the Treatment of Parkinson’s Disease
Current Medicinal Chemistry Amiodarone - A ‘Broad Spectrum’ Antiarrhythmic Drug
Cardiovascular & Hematological Disorders-Drug Targets Immune Response Towards Snake Venoms
Inflammation & Allergy - Drug Targets (Discontinued) Recent Advances of Calcium Phosphate Nanoparticles for Controlled Drug Delivery
Mini-Reviews in Medicinal Chemistry Structural and Functional Characterization of a γ-Type Phospholipase A2 Inhibitor from Bothrops jararacussu Snake Plasma
Current Topics in Medicinal Chemistry Preface: Additional Potential Applications of Angiotensin Converting Enzyme Inhibitors and of Angiotensin II Receptor Antagonists
Current Pharmaceutical Design